Navigation Links
Ivivi's PEMF Technology Significantly Improves Neuron Survival in,Parkinson's Disease Model, Study Finds

ustomers to receive third party reimbursement, the inability to obtain additional capital, the inability to protect the Company's intellectual property, the loss of any executive officers or key personnel or consultants, competition, changes in the regulatory landscape or the imposition of regulations that affect the Company's products and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission, including the Company's registration statement on Form SB-2. The Company assumes no obligation to update the information contained in this press release.

Contact

Investor Relations:
Cameron Associates
Alison Ziegler or Lester Rosenkrantz, 212-554-5469
Alison@cameronassoc.com
or
Media:
Deanne Eagle, 212-554-5463
Deanne@cameronassoc.com
or
Public Relations:
Avalanche Strategic Communications
Denyse Dabrowski, 201-488-0049
Mobile: 201-916-7122
Denyse@avalanchepr.com


'"/>




Page: 1 2 3

Related medicine technology :

1. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
2. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
6. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
10. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
11. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Post Your Comments:
(Date:9/14/2014)... , Sept. 14, 2014  Amgen (NASDAQ: AMGN ) ... ystolic H eart failure treatment with the ... T rial) study evaluating ivabradine in patients with chronic ... Annual Scientific Meeting of the Heart Failure Society of America ... analysis from the SHIFT study confirmed low systolic blood pressure ...
(Date:9/14/2014)... Sept. 14, 2014  Abbott announced today positive ... first prospective, randomized, controlled trial comparing the safety ... to Abbott,s market-leading metallic XIENCE family of DES.  ... , included 501 people with coronary artery ... disease. The results were featured at a late-breaking ...
(Date:9/13/2014)... , Sept. 13, 2014  Edwards Lifesciences ... leader in the science of heart valves and ... clinical outcomes for inoperable patients treated in The ... for transcatheter aortic valve replacement (TAVR) in patients ... were presented as part of the late-breaking clinical ...
Breaking Medicine Technology:Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 2Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 3Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 5Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 6Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 7Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 8Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data 2
... Sanmina-SCI Corporation (Nasdaq: SANM ), a ... world,s most complex and valuable electronic and mechanical ... has been awarded ISO 13485 certification for medical ... manufacturing capabilities, and the company,s focus on meeting ...
... Sept. 8, 2011 Marshall Edwards, Inc. (Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... of the Company,s lead drug candidate ME-143 in patients ... in collaboration with the Sarah Cannon Research Institute in ...
Cached Medicine Technology:Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 3Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3
(Date:9/14/2014)... In the recent years, there has been a ... an increase in the number of web hosting companies ... very affordable prices. , The famous SEO hosting review ... suppliers and announced that Bluehost ( http://www.bluehost.com/track/seohosts ), Arvixe ... 2014. Those who want to obtain high quality WordPress ...
(Date:9/13/2014)... (PRWEB) September 14, 2014 Recently, an ... gowns, iFitDress.com, has announced its new collection of ... them are offered at discounted rates, up to 58% ... will be valid until September 23. , The ... in the market, including vintage, plus size, modest, sexy ...
(Date:9/13/2014)... New York, NY (PRWEB) September 13, 2014 ... developers and medical device manufacturers turn to operators ... improve operating efficiencies and manage risk. “Over the ... increased due to technological advances in the healthcare ... IBISWorld Industry Analyst Jocelyn Phillips. Moreover, the 2010 ...
(Date:9/13/2014)... HealthDay Reporter SATURDAY, Sept. 13, 2014 (HealthDay ... being treated at a Nebraska medical center is getting his ... been a patient in the hospital,s isolation unit since being ... On Friday, the hospital said that Sacra satisfied a ... Jerry,s Chocolate Chip Cookie Dough, the Associated Press ...
(Date:9/13/2014)... 2014 Gainesville Fit Body Boot ... their official Grand Opening celebration today, Saturday, September 13th, ... international Fit Body Boot Camp franchise, which is known ... get busy people the fast results they’re looking for ... are hard work, but we make them fun as ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers Bluehost, GoDaddy and Arvixe as the Best SEO Hosting Suppliers 2Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Healthcare Consultants in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:American Ebola Patient Gets Appetite Back 2Health News:American Ebola Patient Gets Appetite Back 3Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 2Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 3
... Texas, an enzyme has been found, that instigates the growth ... the stem cells to step up production and replace lost ... enzyme may also spur the growth of stem cells elsewhere ... to harness the potential of adult stem cells to treat ...
... the contrary, researchers reported, that mild depression may probably ... University Medical Center in Durham, studied 3500 men and ... three years from 1989 to 1999. The interview subjects ... participants were married, some widowed and some divorced. Some ...
... winning screenwriters have a lower life expectancy than nominees who ... health and longevity - but it doesn't always follow. //A ... winning an Academy Award. ,They looked at all ... winners had a lower life expectancy - by an average ...
... glass of beer daily appears to protect against colon cancer ... is the ingredients in beer, not the alcohol content, that ... researcher with the Kirin Brewery Co. in Yokohama, Japan, said ... hops, malt or beer -- Kirin pilsner -- and also ...
... exercise during treatment for breast cancer can improve bone ... measures. Roenann Roubenoff, from Tufts University, presented the finding ... stood in, as the researchers were unable to present. ... nice adjunct to therapy and people can feel empowered ...
... boys with anorexia can develop debilitated bones as a ... anorexic boys, like girls with the disorder, can "catch-up" ... to normal weights.// , Dr. Josefina Castro of ... a relatively short duration of anorexic disorder can already ...
Cached Medicine News:Health News:Enzyme stimulates growth of adult stem cells 2Health News:Mild Depression may guard aged women 2Health News:Exercise for patients with cancer 2Health News:Anorexia in boys is common too 2
Flattened 13 mm "Graefe type" hook, with 1.5 mm oval hole. Flat serrated handle with polished finish. Overall length: 5.6 inches....
Fine short working end. Overall length: 4.9 inches. Most popular size or model....
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall ...
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Medicine Products: